Patents Assigned to Esperance Pharmaceuticals
  • Methods for diagnosis of and predicting treatment efficacy of hormone receptor expressing tumors, cancers and neoplasias
    Patent number: 10093961
    Abstract: The invention relates to diagnosis, detection, screening, identifying and predicting methods. In various embodiments, methods of the invention include diagnosis, detection, or screening for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) in the subject; identifying a subject that will or is likely to respond to a therapy for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia); and predicting therapeutic efficacy of a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) treatment in a subject.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: October 9, 2018
    Assignee: ESPERANCE PHARMACEUTICALS
    Inventors: Carola Leuschner, Hector Alila
  • Lytic domain fusion constructs and methods of making and using same
    Patent number: 8318899
    Abstract: The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.
    Type: Grant
    Filed: January 26, 2009
    Date of Patent: November 27, 2012
    Assignees: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Esperance Pharmaceuticals
    Inventors: Carola Leuschner, Hector Alila
  • METHODS FOR DIAGNOSIS OF AND PREDICTING TREATMENT EFFICACY OF HORMONE RECEPTOR EXPRESSING TUMORS, CANCERS AND NEOPLASIAS
    Publication number: 20110217702
    Abstract: The invention relates to diagnosis, detection, screening, identifying and predicting methods. In various embodiments, methods of the invention include diagnosis, detection, or screening for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) in the subject; identifying a subject that will or is likely to respond to a therapy for a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia); and predicting therapeutic efficacy of a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) treatment in a subject.
    Type: Application
    Filed: December 21, 2010
    Publication date: September 8, 2011
    Applicant: ESPERANCE PHARMACEUTICALS
    Inventors: CAROLA LEUSCHNER, Hector Alila
  • LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
    Publication number: 20090269341
    Abstract: The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.
    Type: Application
    Filed: January 26, 2009
    Publication date: October 29, 2009
    Applicant: Esperance Pharmaceuticals
    Inventors: CAROLA LEUSCHNER, Hector Alila
  • LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
    Publication number: 20090233860
    Abstract: The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.
    Type: Application
    Filed: March 5, 2009
    Publication date: September 17, 2009
    Applicants: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY & AGRICULTURAL & MECHANICAL COLLEGE, ESPERANCE PHARMACEUTICALS
    Inventors: CAROLA LEUSCHNER, HECTOR ALILA
  • LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME
    Publication number: 20090233861
    Abstract: The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.
    Type: Application
    Filed: March 5, 2009
    Publication date: September 17, 2009
    Applicants: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE, ESPERANCE PHARMACEUTICALS
    Inventors: CAROLA LEUSCHNER, HECTOR ALILA